5T33 myeloma idiotype immunoglobulin (5T33MM Id)

The 5T33 myeloma idiotype immunoglobulin is a tumor-specific antigen derived from the 5T33MM murine model, which is widely used to study human multiple myeloma (Radl et al., 1988). This molecule consists of the unique variable regions (idiotypes) of the monoclonal immunoglobulin, or M-protein, produced by malignant plasma cells. Because the idiotype is unique to the malignant clone, it serves as an ideal target for personalized immunotherapy without affecting the normal B-cell repertoire (Van Riet et al., 1991). In the 5T33MM model, this immunoglobulin is secreted into the serum and can also be found on the surface of the myeloma cells as a B-cell receptor. Therapeutic strategies targeting this molecule include idiotype-pulsed dendritic cell vaccines and DNA vaccines designed to break immune tolerance (Asosingh et al., 2000). These interventions aim to induce idiotype-specific cytotoxic T lymphocytes and antibodies that recognize and destroy the tumor cells. Despite its specificity, the 5T33 idiotype is often weakly immunogenic, necessitating the use of potent adjuvants or cytokine support to achieve efficacy. Monitoring the levels of this idiotype in the serum serves as a critical biomarker for disease progression and response to therapy in experimental settings.

Other names

5T33 monoclonal protein5T33 M-protein5T33MM idiotype5T33 myeloma antigen5T33 B-cell receptor

Induction of a specific cellular and humoral immune response against the unique variable regions (idiotypes) of the monoclonal immunoglobulin produced by malignant plasma cells, leading to the targeted destruction of the tumor clone.